AFT PHARMACEUTICALS

AFT
End-of-day quote. End-of-day quote  - 11/26
4.8NZD +2.13%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The Company's NasoSURF Nebuliser is in pilot scale production. The Company is focused on conducting clinical for Maxigesic oral dose forms. The Company is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.
Sales per Business
20192020
NZD
(in Million)
%NZD
(in Million)
%
Pharmaceutical 83.6598.3% 101.4296%
Licensing 1.221.4% 3.833.6%
Royalties 0.2550.3% 0.3560.3%
Sales per region
20192020
NZD
(in Million)
%NZD
(in Million)
%
Australia 50.3059.1% 61.4358.2%
New Zealand 26.8031.5% 30.1128.5%
Rest of World 5.896.9% 9.138.6%
Southeast Asia 2.142.5% 4.934.7%
Managers
Name Title
Hartley Atkinson Chief Executive Officer, Executive Director & MD
David Mark Flacks Chairman
Malcolm Tubby Chief Financial Officer & Secretary
Douglas John Wilson Independent Non-Executive Director
Marree Atkinson Executive Director & Chief of Staff
Jon Lamb Independent Non-Executive Director
James S. Burns Independent Non-Executive Director
Anita Baldauf Non-Executive Director
Murray Keith Marketing Manager
Vladimir Ilievski Manager-Regulatory Affairs
Shareholders
Name Equities %
Hartley Atkinson 1,617,818 1.55%
Accident Compensation Corp. 852,002 0.81%
Guardians of New Zealand Superannuation 737,134 0.70%
Jon Lamb 248,094 0.24%
Joeri Yvonne Jozef Sels 220,642 0.21%
Hamish Atkinson 190,000 0.18%
David Mark Flacks 178,764 0.17%
Joseph Wallace Carson 150,000 0.14%
James S. Burns 125,417 0.12%
Malcolm Tubby 93,892 0.090%
Company contact information
AFT Pharmaceuticals Ltd.
Nielsen House
129 Hurstmere Road, Takapuna
Level 1
Auckland 0622

Phone : +64.800.423.823
Fax : +64.800.423.874
Web : http://www.aftpharm.com
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
AFT PHARMACEUTICALS LIMITED37.14%351
JOHNSON & JOHNSON-1.50%378 244
ROCHE HOLDING AG-4.41%282 585
PFIZER INC.-1.59%203 048
NOVARTIS AG-11.88%202 620
MERCK & CO., INC.-11.97%202 555
ABBVIE INC.17.69%183 962
NOVO NORDISK A/S6.40%152 415
BRISTOL-MYERS SQUIBB COMPANY-2.10%142 003
ASTRAZENECA PLC1.85%137 013
ELI LILLY AND COMPANY10.13%131 228
AMGEN INC.-8.61%128 258
SANOFI-6.03%126 012
GLAXOSMITHKLINE PLC-21.87%91 855
CHUGAI PHARMACEUTICAL CO., LTD.42.95%73 525
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 214
DAIICHI SANKYO COMPANY, LIMITED56.60%68 978
BAYER AG-32.50%57 498
TAKEDA PHARMACEUTICAL COMPANY LIMITED-15.03%55 234
ASTELLAS PHARMA INC.-15.08%28 729
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED36.49%26 384